Lack of competition doesn’t just lead to higher prices, it stifles innovation
This week’s testimony in the merger trial of Anthem and Cigna has been more focused on innovation than the first week, which largely laid...
Unsealed court documents show deep divide between merging parties
Testimony from Anthem CEO Joe Swedish and Cigna CEO David Cordani has been unsealed following a request from Judge Jackson for greater...
Most recent horizontal merger case offers clues for Anthem outcome
We wrote last week on our blog that the judge assigned to the Anthem-Cigna merger is likely to look at recent precedent, specifically...
Transparency at Issue in Merger Trial
Transparency is a hot topic in politics right now, but yesterday at the trial of Anthem and Cigna, we got a reminder that judicial...
Anthem-Cigna Trial Off to Fascinating Start
The trial began today to challenge the $48 billion merger between Anthem and Cigna, two of the nation’s largest health insurers. The suit...
How to talk about the merger trials like a pro
In the complaint filed by the DOJ to enjoin the merger of Anthem and Cigna, the merger is characterized as an attempt to “combine the few...
Good on paper isn’t good enough
Customers count for a lot in merger cases. Congress passed the Clayton Act 102 years ago because the traditional tools of antitrust...
Anthem-Cigna trial one week away
The parties in the trial of Anthem and Cigna met today for a pretrial conference, in which they would discuss “mechanics, not merits,” as...
The election won't matter for health insurance merger trials
As millions contemplate the meaning of the election of Donald Trump as our 45th President, some might speculate this may lead to the...
Sovaldi paved the way for 2016 drug price fight
At the beginning of this year, Massachusetts Attorney General Maura Healey sent a letter to Gilead Pharmaceuticals asking the company to...
